CARGO Therapeutics, Inc. (CRGX) has shared an announcement.
CARGO Therapeutics, Inc. has expanded its Board of Directors from six to seven, appointing Dr. Kapil Dhingra as the new member. With a rich background in healthcare consulting and considerable experience on various boards, including his current role as Managing Member of KAPital Consulting, LLC, Dr. Dhingra brings valuable expertise to the table. His appointment as a Class II director is set until the 2025 annual stockholders’ meeting. Dr. Dhingra’s compensation includes an annual retainer and an initial option grant for company stock, in line with the company’s non-employee director compensation program.
For a thorough assessment of CRGX stock, go to TipRanks’ Stock Analysis page.
